Neuropace Inc
NASDAQ:NPCE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
F
|
FBR Ltd
OTC:FBRKF
|
AU |
|
IRIDEX Corp
NASDAQ:IRIX
|
US |
|
E
|
Enerflex Ltd
F:7EX
|
CA |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
DUS:LSPP
|
CH |
|
M
|
Masoval AS
OSE:MAS
|
NO |
|
S
|
Summit Hotel Properties Inc
F:SDP
|
US |
|
Alpha Teknova Inc
NASDAQ:TKNO
|
US |
|
U
|
Ucb SA
F:UNC
|
BE |
|
K
|
Korea Computer Terminal Inc
KOSDAQ:089150
|
KR |
|
S
|
Silver Dollar Resources Inc
F:4YW
|
CA |
|
AI/ML Innovations Inc
F:42FB
|
CA |
|
T
|
Theralase Technologies Inc
OTC:TLTFF
|
CA |
|
A
|
Adgar Investments and Development Ltd
TASE:ADGR
|
IL |
|
T
|
Tokuyama Corp
F:TBT
|
JP |
|
P
|
PayPoint plc
OTC:PYPTF
|
UK |
|
K
|
Kadestone Capital Corp
OTC:KDCCF
|
CA |
|
Clean Motion AB
F:66M
|
SE |
Bankruptcy Probability
Neuropace Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Neuropace Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Neuropace Inc
NASDAQ:NPCE
|
424.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
170.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
147B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
105.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
60.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Neuropace Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Neuropace Inc has total debt of 59m USD. This includes both short-term (0 USD) and long-term (59m USD) debt.
You can find a full breakdown on its Balance Sheet.